These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31518346)

  • 21. Successful treatment of persistent MRSA bacteremia using high-dose daptomycin combined with rifampicin.
    Hagiya H; Terasaka T; Kimura K; Satou A; Asano K; Waseda K; Hanayama Y; Otsuka F
    Intern Med; 2014; 53(18):2159-63. PubMed ID: 25224207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro efficacy of fosfomycin-containing regimens against methicillin-resistant Staphylococcus aureus in biofilms.
    Tang HJ; Chen CC; Cheng KC; Toh HS; Su BA; Chiang SR; Ko WC; Chuang YC
    J Antimicrob Chemother; 2012 Apr; 67(4):944-50. PubMed ID: 22258931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm.
    El Haj C; Murillo O; Ribera A; Lloberas N; Gómez-Junyent J; Tubau F; Fontova P; Cabellos C; Ariza J
    Int J Antimicrob Agents; 2018 Jun; 51(6):854-861. PubMed ID: 29374577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
    Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
    Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sub-Inhibitory Concentrations of Oxacillin, but Not Clindamycin, Linezolid, or Tigecycline, Decrease Staphylococcal Phenol-Soluble Modulin Expression in Community-Acquired Methicillin-Resistant Staphylococcus aureus.
    Hodille E; Beraud L; Périan S; Berti V; Bes M; Tristan A; Blond E; Lina G; Dumitrescu O
    Microbiol Spectr; 2022 Feb; 10(1):e0080821. PubMed ID: 35044221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting effects of antibiotic combinations using MICs determined at pharmacokinetically derived concentration ratios: in vitro model studies with linezolid- and rifampicin-exposed Staphylococcus aureus.
    Golikova MV; Strukova EN; Portnoy YA; Dovzhenko SA; Kobrin MB; Zinner SH; Firsov AA
    J Chemother; 2017 Oct; 29(5):267-273. PubMed ID: 28192070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Linezolid and Fosfomycin in Catheter-Related Biofilm Infection Caused by Methicillin-Resistant Staphylococcus aureus.
    Chai D; Liu X; Wang R; Bai Y; Cai Y
    Biomed Res Int; 2016; 2016():6413982. PubMed ID: 27366751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of daptomycin & linezolid against methicillin resistant Staphylococcus aureus & vancomycin resistant enterococci isolated from hospitalized cases in Central India.
    Chitnis S; Katara G; Hemvani N; Pareek S; Chitnis DS
    Indian J Med Res; 2013 Jan; 137(1):191-6. PubMed ID: 23481072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of Different Antistaphylococcal Therapies, Alone or Combined, in a Rat Model of Methicillin-Resistant Staphylococcus epidermidis Osteitis without Implant.
    Albac S; Labrousse D; Hayez D; Anzala N; Bonnot D; Chavanet P; Aslangul E; Croisier D
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31740562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Investigation of antibiotic resistance patterns and reduced vancomycin susceptibilities of methicillin-resistant Staphylococcus aureus isolates: a multi-center study].
    Çıkman A; Aydın M; Gülhan B; Parlak M; Gültepe B; Kalaycı Y; Bayındır Bilmen F; Solmaz S; Özekinci T
    Mikrobiyol Bul; 2015 Apr; 49(2):240-8. PubMed ID: 26167824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Sacar M; Sacar S; Kaleli I; Onem G; Turgut H; Goksin I; Ozcan V; Kaan Inan B; Duver H; Baltalarli A
    J Surg Res; 2007 May; 139(2):170-5. PubMed ID: 17292421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing the cost-effectiveness of linezolid to trimethoprim/sulfamethoxazole plus rifampicin for the treatment of methicillin-resistant Staphylococcus aureus infection: a healthcare system perspective.
    von Dach E; Morel CM; Murthy A; Pagani L; Macedo-Vinas M; Olearo F; Harbarth S
    Clin Microbiol Infect; 2017 Sep; 23(9):659-666. PubMed ID: 28232163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.
    Jang HC; Kim SH; Kim KH; Kim CJ; Lee S; Song KH; Jeon JH; Park WB; Kim HB; Park SW; Kim NJ; Kim EC; Oh MD; Choe KW
    Clin Infect Dis; 2009 Aug; 49(3):395-401. PubMed ID: 19569970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of linezolid plus rifampin in an experimental model of methicillin-susceptible Staphylococcus aureus endocarditis.
    Dailey CF; Pagano PJ; Buchanan LV; Paquette JA; Haas JV; Gibson JK
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2655-8. PubMed ID: 12878535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Observed Antagonistic Effect of Linezolid on Daptomycin or Vancomycin Activity against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic Model.
    Luther MK; LaPlante KL
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7790-4. PubMed ID: 26369963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of dosing regimens of vancomycin, teicoplanin, linezolid and daptomycin against methicillin-resistant
    Wei X; Zhao M; Xiao X
    J Chemother; 2021 Dec; 33(8):547-553. PubMed ID: 34080519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetically-based prediction of the effects of antibiotic combinations on resistant Staphylococcus aureus mutants: in vitro model studies with linezolid and rifampicin.
    Firsov AA; Golikova MV; Strukova EN; Portnoy YA; Dovzhenko SA; Kobrin MB; Zinner SH
    J Chemother; 2017 Aug; 29(4):220-226. PubMed ID: 27748167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of rifampicin resistance in methicillin-resistant Staphylococcus aureus in tuberculosis wards.
    Sekiguchi J; Fujino T; Araake M; Toyota E; Kudo K; Saruta K; Yoshikura H; Kuratsuji T; Kirikae T
    J Infect Chemother; 2006 Feb; 12(1):47-50. PubMed ID: 16506090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
    Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
    Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.